Uncategorized

The divestiture “fortifies our confidence” to reach positive cash flow in 2026, said Amwell CEO Ido Schoenberg.

The year-long inquiry into hospitals managed by Apollo Global Management and Leonard Green & Partners comes amid growing calls for increased oversight of private equity in healthcare.

The bevy of changes for the massive California nonprofit is meant to improve operations, and should also give Blue Shield a financial leg-up as it competes with well-funded for-profit peers.

In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros’ product in certain U.S. spine geographies.

Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 deals in 2023.

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.

Nearly 30% of the funding poured into healthcare startups last year went to companies leveraging artificial intelligence, according to Silicon Valley Bank.

The company’s lead asset is a potentially first-in-class oral GLP-1 receptor agonist that has the potential to be dosed weekly, which according to CEO Khurem Farooq can help improve accessibility and affordability.

Una nueva técnica, que podemos describir coloquialmente como “linterna molecular”, detecta metástasis cerebral introduciendo en el cerebro una sonda de luz más fina que un cabello. Es capaz de informar sobre la composición química del tejido nervioso y …

MaaT013 in 2022 was put under clinical hold by the FDA, which cited safety and efficacy concerns with the sample-pooling method used to produce the investigational therapy. The hold was lifted in April 2023.